• PDK4-IN-1 Hydrochloride: Practical Research Workflows

  2026-09-27

  Use PDK4-IN-1 hydrochloride to connect selective PDK4 inhibition with PDH activation and measurable changes in cellular metabolism. This workflow separates target engagement from downstream phenotype, helping researchers choose informative metabolic, cardiac, or tumor-model experiments without confusing preclinical findings with therapeutic proof.

• Leptin (116-130), amide, mouse: Assay Guide

  2026-09-26

  A practical guide to evaluating Leptin (116-130), amide, mouse, in cell viability, proliferation, and cytotoxicity workflows. It explains formulation controls, cautious interpretation, and how to assess SKU A1024 without assuming unreported assay performance.

• From Labeling Chemistry to Translational Evidence

  2026-09-25

  Reliable fluorescence is more than a bright signal: it is a design choice that can shape the quality of molecular characterization and translational decisions. This article explains how 6-FAM SE supports durable amine-reactive labeling, connects assay strategy to a glutathione-responsive melanoma nanomedicine study, and clarifies what fluorescent tracking can—and cannot—establish.

• Dehydroepiandrosterone (DHEA): Assay Workflows

  2026-09-25

  Practical guidance for selecting, dissolving, dosing, and interpreting Dehydroepiandrosterone (DHEA) in cell viability, neural survival, and ovarian research. The article covers product specifications for SKU B1375 and distinguishes DHEA-induced PCOS models from experiments using DHEA as a treatment.

• Trifluoperazine 2HCl: Assay Workflows

  2026-09-24

  Use Trifluoperazine 2HCl to probe dopamine D2 receptor signaling, then build a carefully controlled macrophage workflow around ROS and autophagy readouts. The guide separates reported product properties from proposed pilot conditions so researchers can test cross-domain hypotheses without over-attributing effects to D2 inhibition.

• SIRT1–Plk2 Control of Centriole Duplication

  2026-09-24

  Ling and colleagues identify Plk2 as a SIRT1-regulated acetylation substrate and show how their interaction helps time centriole duplication across G1. The work links Plk2 deacetylation to ubiquitin-dependent degradation, while highlighting why broad HDAC inhibition cannot be assumed to reproduce a SIRT1-specific mechanism.

• Cy5 TSA Fluorescence System Kit: Mapping Injury

  2026-09-23

  The Cy5 TSA Fluorescence System Kit can help researchers resolve where low-abundance signals arise in complex tissue, not simply make images brighter. This article connects tyramide chemistry with a recent endothelial-centered model of doxorubicin cardiotoxicity and outlines practical assay-design choices and limitations.

• Vardenafil HCl Trihydrate in PDE5 Research

  2026-09-23

  Build more discriminating PDE5 inhibition assays, smooth muscle relaxation studies, and cGMP pathway experiments with a highly potent reference compound. Native-membrane mass spectrometry findings add a critical selectivity perspective: PDE5 potency does not eliminate the need to examine proteoform-dependent PDE6 interactions.

• Chronic Stress, Brain Mitochondria, and Depression

  2026-09-22

  A 2025 rat study links chronic unpredictable mild stress (CUMS) with mitochondrial dysfunction and inflammatory signaling in the hippocampus and prefrontal cortex. Its use of intracerebroventricular MnTBAP as a mitochondrial redox probe further suggests that impaired mitochondrial function contributes to stress-induced depression-like behavior, although the findings remain preclinical.

• MnTBAP Chloride in Mitochondrial Redox Workflows

  2026-09-22

  MnTBAP Chloride helps researchers test whether mitochondrial superoxide is a driver of oxidative injury, inflammation, or stress-related phenotypes. This guide translates cell, tissue, and chronic-stress evidence into practical workflows, controls, and troubleshooting decisions.

• Dual-Readout mRNA for Translational Delivery Science

  2026-09-21

  Translational mRNA research increasingly depends on separating delivery from functional expression. This thought-leadership article examines how dual fluorescence and bioluminescence readouts, informed by a glioblastoma nanomedicine study, can help researchers optimize carriers, interpret intracellular trafficking, and build more decision-ready development packages.

• PRKX Stabilizes PD-L1 in Immunosuppressive Gastric Cancer

  2026-09-21

  This 2026 study identifies PRKX as a regulator of an immunosuppressive gastric cancer subtype by stabilizing PD-L1 through phosphorylation-dependent inhibition of ubiquitination. Its findings connect single-cell immune stratification with a clinically relevant biomarker and a preclinical combination strategy using PRKX-targeting siRNA and anti-PD-1 therapy.

• PreScission Protease for Condensate Biology

  2026-09-20

  PreScission Protease enables precise, low-temperature fusion-tag removal before sensitive native-protein and condensate assays. This workflow connects HRV 3C protease specificity with practical quality control for dKeap1 oxidative-stress research.

• 4-MUG for Lysosomal Enzyme Activity Assays

  2026-09-19

  4-Methylumbelliferyl-β-D-Glucopyranoside converts β-glucosidase and β-glucocerebrosidase hydrolysis into a sensitive fluorescent signal for cell lysates, purified enzymes, and screening workflows. Its strongest use is as a quantitative activity layer that complements lysosomal localization, glycosphingolipid measurements, and Gaucher disease therapeutic studies.

• DHEA as a Translational Bridge in PCOS and Neuroprotection

  2026-09-18

  Dehydroepiandrosterone (DHEA) is more than a steroid precursor: it is a context-dependent research probe connecting neuroprotection, apoptosis inhibition, granulosa cell biology, and inflammatory ovarian remodeling. This article translates mechanistic evidence into practical study-design guidance.

3629 records 1/242 page Next 12345 下5页 Last page